Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
08/15/2025 | PUT | $23.50 | 2,961 | +2,736 | +1,216.00% |
12/18/2026 | CALL | $40.00 | 16,654 | +2,632 | +18.77% |
08/08/2025 | PUT | $24.00 | 4,656 | +2,048 | +78.53% |
08/01/2025 | PUT | $24.00 | 6,142 | +1,773 | +40.58% |
08/01/2025 | CALL | $24.50 | 2,409 | +1,771 | +277.59% |
08/01/2025 | PUT | $24.50 | 5,348 | +1,646 | +44.46% |
09/19/2025 | CALL | $30.00 | 13,967 | -79 | -0.56% |
09/19/2025 | CALL | $27.00 | 25,757 | -108 | -0.42% |
12/19/2025 | PUT | $35.00 | 1,627 | -193 | -10.60% |
11/21/2025 | CALL | $27.00 | 10,775 | -246 | -2.23% |
12/19/2025 | PUT | $32.50 | 6,949 | -1,496 | -17.71% |
01/16/2026 | PUT | $32.50 | 5,848 | -2,502 | -29.96% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.02% | 170.64M | 6.14B |
Vanguard 500 Index Fund | 2.30% | 129.76M | 4.67B |
Washington Mutual Investors Fund | 1.42% | 80.41M | 2.89B |
Fidelity 500 Index Fund | 1.09% | 61.54M | 2.21B |
SPDR S&P 500 ETF Trust | 1.08% | 60.77M | 2.19B |
American Balanced Fund | 1.00% | 56.61M | 2.04B |
Income Fund of America Inc | 0.93% | 52.68M | 1.9B |
iShares Core S&P 500 ETF | 0.89% | 50.1M | 1.8B |
Vanguard Index-Value Index Fund | 0.86% | 48.51M | 1.75B |
Vanguard Specialized-Health Care Fund | 0.86% | 48.32M | 1.74B |
Basilea initiates phase 3 study with antifungal fosmanogepix in invasive mold infections
07/29 01:15 am
GlobeNewswire Inc.
Read moreBasilea initiiert Phase-3-Studie mit Antipilzmittel Fosmanogepix bei invasiven Schimmelpilzinfektionen
07/29 01:15 am
GlobeNewswire Inc.
Read moreGlobal Dysmenorrhea Treatment Market to Cross ~USD 8 Billion by 2032 | DelveInsight
07/23 01:00 pm
GlobeNewswire Inc.
Read more2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade
07/21 08:15 am
The Motley Fool
Read moreShould You Forget Pfizer and Buy This Magnificent Dividend Stock Instead?
07/20 09:25 am
The Motley Fool
Read more2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 Right Now
07/19 04:27 am
The Motley Fool
Read more4 High-Yield Large-Caps With Dividend Risk and Opportunity in Focus
07/16 02:11 pm
Investing.com
Read moreThis Once-Dominant Healthcare Stock Down 50% Is Finally Ready for a Comeback
07/16 04:12 am
The Motley Fool
Read morePfizer Faces $1 Billion IRA Reform Hit As Analysts Expect Flat 2025 Outlook
07/14 02:39 pm
Benzinga
Read moreFunctional Dyspepsia Market Analysis and Forecast, 2025-2035, Competitive Analysis of AstraZeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong
07/11 04:21 am
GlobeNewswire Inc.
Read moreBurn Pain Market Report 2025-2035 | Focus on Treatment Type, Burn Type, and Country Analysis
07/11 04:20 am
GlobeNewswire Inc.
Read moreBurns Market Analysis and Forecast Report 2025-2035 Featuring Pfizer, Perrigo, Kenvue Brands, 3M, Smith+Nephew, Molnlycke, Cardinal Health, Convatec, Haleon, Coloplast, DeRoyal Industries
07/11 04:19 am
GlobeNewswire Inc.
Read moreRakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development
07/10 04:00 am
GlobeNewswire Inc.
Read moreThis Is the No. 1 Ultra-High-Yield Dividend Stock Held by Retail Investors on Robinhood -- and It's Not Even Close
07/10 03:06 am
The Motley Fool
Read moreThe Best Dividend Stocks I'd Buy Right Now
07/05 06:30 am
The Motley Fool
Read moreWhy I Think Viking Therapeutics Is an Asymmetric Growth Opportunity
07/04 04:30 am
The Motley Fool
Read moreMicroservices in Healthcare Market Size to Hit USD 1,905.26 Million by 2032, Driven by Cloud Adoption and Healthcare Digitization – SNS Insider
06/28 08:00 am
GlobeNewswire Inc.
Read moreWant to Collect $2,000 in Dividends Each Year? Here's How Much You Should Aim to Invest in the Stock Market Today.
06/27 04:22 am
The Motley Fool
Read moreFlu RNA Vaccines Market Research Report 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges
06/20 10:59 am
GlobeNewswire Inc.
Read moreBioNTech’s CureVac Deal Signals Deep Pivot Toward mRNA Cancer Therapies
06/13 11:41 am
Investing.com
Read moreRheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies
06/10 04:53 am
GlobeNewswire Inc.
Read moreSelective Estrogen Receptor Modulators Market Research 2025-2030: Leading Players Shaping the Future of Selective Estrogen Receptor Modulators Industry
06/09 04:56 am
GlobeNewswire Inc.
Read moreNurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)
06/06 07:00 am
GlobeNewswire Inc.
Read moreArvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer
06/06 07:00 am
GlobeNewswire Inc.
Read moreBetter High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis
06/05 03:34 am
The Motley Fool
Read moreHere Are All 6 Stocks I've Bought Through 5 Months of 2025
06/05 03:06 am
The Motley Fool
Read moreStarke Verkaufszahlen für Cresemba® (Isavuconazol) in der Region Asien-Pazifik und China lösen weitere Meilensteinzahlung an Basilea aus
06/05 01:15 am
GlobeNewswire Inc.
Read moreStrong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea
06/05 01:15 am
GlobeNewswire Inc.
Read more3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in June
06/03 03:06 am
The Motley Fool
Read moreCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
06/02 04:00 pm
GlobeNewswire Inc.
Read moreTerrible News for Pfizer Stock Investors
06/01 09:15 am
The Motley Fool
Read moreBeat the S&P 500 With This Cash-Gushing Dividend Stock
06/01 04:14 am
The Motley Fool
Read moreThe World Market for Smoking Cessation & Nicotine De-Addiction Products 2025-2030: Precision Counseling, Targeted Pharmacogenomic Therapies, and Resilient Supply Chains Present Lucrative Opportunities
05/30 04:56 am
GlobeNewswire Inc.
Read morePenicillin Market Research Report 2025 - Global $12.5+ Bn Trends, Opportunities, and Forecasts, 2020-2030F
05/29 10:58 am
GlobeNewswire Inc.
Read morePfizer's Mega Deal Highlights China's Rising Role In Global Pharma
05/29 09:38 am
Benzinga
Read moreNovo Nordisk's 52% Plunge: Is the Company Fumbling Its Leadership in the $150 Billion Weight Loss Market?
05/28 04:15 am
The Motley Fool
Read moreLiposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight
05/27 01:00 pm
GlobeNewswire Inc.
Read moreSchizophrenia Drugs Market Research Report 2025-2035: Advances in Antipsychotic Drug Development, Increasing Prevalence, & Greater Awareness and Access to Mental Health Care Bolster Growth
05/27 10:56 am
GlobeNewswire Inc.
Read moreMadison Realty Capital Originates $720 Million Loan for Office-to-Residential Conversion of Former Pfizer Headquarters
05/25 06:00 pm
GlobeNewswire Inc.
Read moreInvesting for Passive Income? Here's What History Says About the Stability of Dividend King Stocks.
05/25 04:10 am
The Motley Fool
Read moreU.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result
05/24 04:11 am
The Motley Fool
Read morePfizer's 7.5% Dividend: Income Haven or House of Cards?
05/23 05:11 pm
Investing.com
Read moreCERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
05/23 04:00 pm
GlobeNewswire Inc.
Read moreAplastic Anemia Global Clinical Trials Review, 2025 | Explore Trends and Enrollment Data in Aplastic Anemia Clinical Trials
05/20 06:59 am
GlobeNewswire Inc.
Read moreBio/Pharmaceutical Outsourcing Report, March 2025 Edition - Trump Tariffs Drive Pharma Manufacturing to US but Risk Inflation and Disruption
05/19 10:56 am
GlobeNewswire Inc.
Read moreIterum Therapeutics Announces Extension of Term of Promissory Note
05/19 07:00 am
GlobeNewswire Inc.
Read moreDon't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
05/18 12:05 pm
The Motley Fool
Read more3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever
05/14 06:05 pm
The Motley Fool
Read more